Company Search:
Advanced Search
Sponsored Links
Sygnis Ag Company Snapshot
Sygnis Ag operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sygnis Ag with three other companies in this sector in Germany: 4Sc AG (2016 sales of 2.06 million Euro [US$2.55 million] ), Heidelberg Pharma Ag (1.36 million Euro [US$1.69 million] ), and Nanorepro AG (1.54 million Euro [US$1.91 million] ).

Sales Analysis. Sales increased substantially in 2016: During the year ended December of 2016, sales at Sygnis Ag were 1.79 million Euro (US$2.21 million). This is an increase of 222.3% versus 2015, when the company's sales were 555,000.00 Euro. Sales of Other saw an increase of 429.4% in 2016, from 303,000.00 Euro to 1.60 million Euro. Not all segments of Sygnis Ag experienced an increase in sales in 2016: sales of Licenses fell 26.6% to 185,000.00 Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sygnis Ag
  Stock Performance Chart for Sygnis Ag
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 1.44
(Figures in Euro)
1 Week -3.9%   13 Weeks 1.1%  
4 Weeks -8.1%   52 Weeks -4.4%  
Sygnis Ag Key Data:
  Ticker: LIO1 Country: Germany
  Exchanges: DUS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 1,789,000
(Year Ending Jan 2017).
Employees: 47
  Currency: Euro Market Cap: 64,884,822
  Fiscal Yr Ends: December Shares Outstanding: 44,934,087
  Share Type: Stammaktie Closely Held Shares: 15,664,042
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.